ANTH
Price:
$0.001
Market Cap:
$26.18K
Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on developing and commercializing therapeutic solutions for conditions with significant unmet medical needs. The company's pipeline includes Sollpura, an investigational non-porcine pancreatic enzyme replacement therapy in Phase III clinical trials for individuals with exocrine pancreatic insufficiency. It is also advancing Blisibimod, currently in Phase II clinical evaluation for B-cell mediated autoimmune diseases, such as immunoglobulin A nephropathy (IgA nephropathy). Anthera holds licensing agreements with Amgen, Inc. and Eli Lilly and Company. Founded in 2004, the company's base of operations is in Houston, Tex...[Read more]
Industry
Biotechnology
IPO Date
2010-03-01
Stock Exchange
OTC
Ticker
ANTH
According to Anthera Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -485.59%. This represents a change of 84.50% compared to the average of -263.20% of the last 4 quarters.
The mean historical ROE of Anthera Pharmaceuticals, Inc. over the last ten years is 605.27%. The current -485.59% ROE has changed -180.23% with respect to the historical average. Over the past ten years (40 quarters), ANTH's ROE was at its highest in in the March 2012 quarter at 1.54%. The ROE was at its lowest in in the September 2017 quarter at -1358.31%.
Average
605.27%
Median
14.40%
Minimum
-499.55%
Maximum
3.93%
Discovering the peaks and valleys of Anthera Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 797.62%
Maximum Annual ROE = 3.93%
Minimum Annual Increase = -697.56%
Minimum Annual ROE = -499.55%
| Year | ROE | Change |
|---|---|---|
| 2017 | 308.19% | -171.70% |
| 2016 | -429.86% | 388.28% |
| 2015 | -88.03% | -106.57% |
| 2014 | 1.34% | -697.56% |
| 2013 | -224.33% | -113.32% |
| 2012 | 1.68% | -437.22% |
| 2011 | -499.55% | 607.76% |
| 2010 | -70.58% | -171.02% |
| 2009 | 99.39% | -97.47% |
| 2008 | 3.93% | 797.62% |
The current ROE of Anthera Pharmaceuticals, Inc. (ANTH) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-69.90%
5-year avg
181.30%
10-year avg
605.27%
Anthera Pharmaceuticals, Inc.’s ROE is less than PhaseRx, Inc. (101.72%), less than Neurobiological Technologies, Inc. (24.90%), less than Synovics Pharmaceuticals, Inc. (258.22%), less than Cotinga Pharmaceuticals Inc. (132.92%), greater than Sienna Biopharmaceuticals, Inc. (-59.78%), less than Comera Life Sciences Holdings, Inc. (47.45%), less than SheerVision, Inc. (16.68%), greater than GlobeImmune, Inc. (-64.41%), less than OncoVista Innovative Therapies, Inc. (57.94%), less than Viveon Health Acquisition Corp. (-0.50%),
| Company | ROE | Market cap |
|---|---|---|
| 101.72% | $1.17K | |
| 24.90% | $2.70K | |
| 258.22% | $2.98K | |
| 132.92% | $2.20K | |
| -59.78% | $3.09K | |
| 47.45% | $3.07K | |
| 16.68% | $2.55K | |
| -64.41% | $575.00 | |
| 57.94% | $2.36K | |
| -0.50% | $66.49M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anthera Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Anthera Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Anthera Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Anthera Pharmaceuticals, Inc. (ANTH)?
What is the highest ROE for Anthera Pharmaceuticals, Inc. (ANTH)?
What is the 3-year average ROE for Anthera Pharmaceuticals, Inc. (ANTH)?
What is the 5-year average ROE for Anthera Pharmaceuticals, Inc. (ANTH)?
How does the current ROE for Anthera Pharmaceuticals, Inc. (ANTH) compare to its historical average?